CVS Health (CVS) Tops Q2 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
CVS Health Reports Second Quarter Results
August 8, 2018 6:55 AM EDTWOONSOCKET, R.I., Aug. 8, 2018 /PRNewswire/ --
Second Quarter Year-over-Year Highlights:
Net revenues increased 2.2% to $46.7 billion Same store prescription volume growth of 9.5% GAAP earnings (loss) per share from continuing operations of $(2.52), including a $3.9 billion, or $(3.85) per share, goodwill impairment charge related to the Long-term Care ("LTC") business Adjusted EPS of $1.69Year-to-date Highlights:
Generated cash flow from operations of $5.3 billion; free cash flow of $4.4 billion2018 Full Year Guidance:
Revised full year GAAP diluted... More